Detalhe da pesquisa
1.
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 97(5): 562-573, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132679
2.
Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia.
Int J Mol Sci
; 23(17)2022 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077202
3.
Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.
Br J Haematol
; 192(2): 322-332, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32478420
4.
The Importance of Alpha-Actinin Proteins in Platelet Formation and Function, and Their Causative Role in Congenital Macrothrombocytopenia.
Int J Mol Sci
; 22(17)2021 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502272
5.
All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Eur J Haematol
; 104(3): 236-250, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811682
6.
Physician and practice characteristics associated with immunoglobulin test ordering.
Fam Pract
; 35(1): 41-46, 2018 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968810
7.
Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
Br J Haematol
; 198(1): e10-e14, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417566
8.
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Mol Pharm
; 14(3): 940-952, 2017 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146632
9.
A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias.
Br J Haematol
; 175(2): 318-330, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27432187
10.
Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
Blood Cells Mol Dis
; 87: 102521, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33254033
11.
Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Blood
; 123(15): 2389-400, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24516045
12.
Theranostic drug test incorporating the bone-marrow microenvironment can predict the clinical response of acute myeloid leukaemia to chemotherapy.
Br J Haematol
; 189(6): e254-e258, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342487
13.
Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.
Exp Cell Res
; 324(1): 1-12, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694321
14.
Challenges of providing biochemistry results in a patient with Evans syndrome.
Biochem Med (Zagreb)
; 34(1): 011001, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125617
15.
Dealing with digital paralysis: Surviving a cyberattack in a National Cancer center.
J Cancer Policy
; 39: 100466, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176467
16.
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
Br J Haematol
; 163(1): 118-22, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23909468
17.
Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein.
Am J Hematol
; 88(6): 455-62, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23440701
18.
Experiences of and preferences for self-management among low grade non-Hodgkin's lymphoma survivors: A qualitative interview study.
Eur J Oncol Nurs
; 66: 102378, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506608
19.
All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.
Front Oncol
; 12: 848517, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280824
20.
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.
Front Oncol
; 12: 909615, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837095